Evidence map›Paper›PMID 29702694›Full record

ArticlePloS one2018

Test selection for antibody detection according to the seroprevalence level of Schmallenberg virus in sheep.

Srđan Pejaković, Laëtitia Wiggers, Damien Coupeau, Nathalie Kirschvink, James Mason, Benoît Muylkens

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Srđan PejakovićNAmur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
Laëtitia WiggersNAmur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
Damien CoupeauNAmur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
Nathalie KirschvinkNAmur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
James MasonSchool of Biochemistry & Immunology, Trinity College Dublin, the University of Dublin, Dublin, Ireland.
Benoît MuylkensNAmur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.ORCID 0000-0001-5616-5099

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schmallenberg virus (SBV), initially identified in Germany in 2011, spread rapidly throughout Europe causing significant economic losses in ruminant livestock. The ability to correctly detect emerging and re-emerging diseases such as SBV with reliable tests is of high importance. Firstly, we tested diagnostic performance, specificity, and sensitivity of three different assays used in SBV antibody detection using control sheep samples of determined status. After obtaining the results from the control samples, we assessed the potential of the assays to detect previously infected animals in field situations. The samples were investigated using IDEXX Schmallenberg virus Antibody Test Kit, ID Screen Schmallenberg virus Competition Multi-species ELISA and Serum Neutralisation Test (SNT). Analysis of control samples revealed that SNT was the most suitable test, which was therefore used to calculate concordance and test performance for the two other ELISA tests. To evaluate whether different assay performances had an impact under field conditions, sheep samples from two different contexts were tested: the emergence of SBV in Ireland and the re-emergence of SBV in Belgium. Comparing the results obtained from different assays to the non-reference standard assay SNT, we showed considerable differences in estimates of their sensitivity to detect SBV antibodies and to measure seroprevalence of the sheep flocks. Finally, a calculation of the number of randomly selected animals that needs to be screened from a finite flock, showed that SNT and ID.Vet are the most suitable to detect an introduction of the disease in low seroprevalence situations. The IDEXX ELISA test was only able to detect SBV antibodies in a higher seroprevalence context, which is not optimal for monitoring freedom of disease and surveillance studies.

Indexed as

OrthobunyavirusAnimalsAntibodies, ViralBelgiumBunyaviridae InfectionsEnzyme-Linked Immunosorbent AssayGermanyImmunologic TestsIrelandNeutralization TestsSensitivity and SpecificitySeroepidemiologic StudiesSheepSheep DiseasesAntibodies, Viral

Identifiers

PMID29702694
PMCPMC5922541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.